MedTrace Logo

The Performance of Dexcom G6 Glucose Monitoring in Critically Ill Patients

NCT05255783 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2024-11-22

No results posted yet for this study

Summary

This is an investigator-initiated, prospective, observational accuracy-study. The aim of the study is to test the feasibility, safety, and accuracy of a subcutaneous continuous glucose monitoring system (the Dexcom G6 glucose monitoring system) in critically ill patients. A total of 40 adult patients admitted to the intensive care unit requiring intravenous insulin infusion to maintain blood glucose within target range will be enrolled. Subcutaneous glucose readings will be compared with routine arterial blood glucose measurements to determine accuracy.

Conditions

  • Blood Glucose
  • Humans
  • Critical Care

Interventions

DEVICE

subcutaneous continuous glucose sensor

Dexcom G6 continuous glucose monitoring system

Sponsors & Collaborators

  • DexCom, Inc.

    collaborator INDUSTRY

  • Region Stockholm

    lead OTHER_GOV

Principal Investigators

  • Johan Mårtensson, MD, PhD · Karolinska University Hospital

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-19
Primary Completion
2023-05-15
Completion
2023-05-15
FDA Device
Yes

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05255783 on ClinicalTrials.gov